Literature DB >> 24908174

Human CNS immune senescence and neurodegeneration.

Wolfgang J Streit1, Qing-Shan Xue2.   

Abstract

Microglial cells comprising the brain's immune system are essential for ensuring neuroprotection in the normal and pathological CNS. On the basis of histopathological observations in human brain, we believe that the ability of microglia to provide neuroprotection deteriorates as our brains get older and that such CNS immune senescence is a major factor contributing to the development of aging-related neurodegenerative diseases, notably Alzheimer's disease. The idea is consistent with the fact that immune senescence occurs naturally in the periphery, rendering the elderly people more susceptible to infections and cancers. There is an analogous situation in the brain, except that here the main impact comes down to diminished neuroprotection and resultant neurodegeneration.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24908174     DOI: 10.1016/j.coi.2014.05.005

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  36 in total

Review 1.  Central nervous system myeloid cells as drug targets: current status and translational challenges.

Authors:  Knut Biber; Thomas Möller; Erik Boddeke; Marco Prinz
Journal:  Nat Rev Drug Discov       Date:  2015-12-04       Impact factor: 84.694

2.  Microglial cell activation and senescence are characteristic of the pathology FXTAS.

Authors:  Verónica Martínez Cerdeño; Tiffany Hong; Sarwat Amina; Mirna Lechpammer; Jeanelle Ariza; Flora Tassone; Stephen C Noctor; Paul Hagerman; Randi Hagerman
Journal:  Mov Disord       Date:  2018-12-10       Impact factor: 10.338

Review 3.  Neuroinflammation in glaucoma: A new opportunity.

Authors:  Pete A Williams; Nick Marsh-Armstrong; Gareth R Howell
Journal:  Exp Eye Res       Date:  2017-02-24       Impact factor: 3.467

4.  TREM2 regulates microglial cell activation in response to demyelination in vivo.

Authors:  Claudia Cantoni; Bryan Bollman; Danilo Licastro; Mingqiang Xie; Robert Mikesell; Robert Schmidt; Carla M Yuede; Daniela Galimberti; Gunilla Olivecrona; Robyn S Klein; Anne H Cross; Karel Otero; Laura Piccio
Journal:  Acta Neuropathol       Date:  2015-01-29       Impact factor: 17.088

Review 5.  Estrogens, Neuroinflammation, and Neurodegeneration.

Authors:  Alessandro Villa; Elisabetta Vegeto; Angelo Poletti; Adriana Maggi
Journal:  Endocr Rev       Date:  2016-05-19       Impact factor: 19.871

Review 6.  Immunotherapeutic approaches for Alzheimer's disease.

Authors:  Thomas Wisniewski; Fernando Goñi
Journal:  Neuron       Date:  2015-03-18       Impact factor: 17.173

7.  Combination of Aβ Suppression and Innate Immune Activation in the Brain Significantly Attenuates Amyloid Plaque Deposition.

Authors:  Christophe Verbeeck; Anna Carrano; Paramita Chakrabarty; Joanna L Jankowsky; Pritam Das
Journal:  Am J Pathol       Date:  2017-09-15       Impact factor: 4.307

8.  Old age increases microglial senescence, exacerbates secondary neuroinflammation, and worsens neurological outcomes after acute traumatic brain injury in mice.

Authors:  Rodney M Ritzel; Sarah J Doran; Ethan P Glaser; Victoria E Meadows; Alan I Faden; Bogdan A Stoica; David J Loane
Journal:  Neurobiol Aging       Date:  2019-02-20       Impact factor: 4.673

Review 9.  Developing therapeutic vaccines against Alzheimer's disease.

Authors:  Thomas Wisniewski; Eleanor Drummond
Journal:  Expert Rev Vaccines       Date:  2015-12-11       Impact factor: 5.217

10.  Age-dependent differences in microglial responses to systemic inflammation are evident as early as middle age.

Authors:  Maria Nikodemova; Alissa L Small; Rebecca S Kimyon; Jyoti J Watters
Journal:  Physiol Genomics       Date:  2016-02-16       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.